TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019

Liver fibrosis is an advanced liver disease condition, which could progress to cirrhosis and hepatocellular carcinoma. To date, there is no direct approved antifibrotic therapy, and current treatment is mainly the removal of the causative factor. Transforming growth factor (TGF)-β is a master profib...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewidar, Bedair, Meyer, Christoph, Dooley, Steven, Meindl-Beinker, Nadja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912224/
https://www.ncbi.nlm.nih.gov/pubmed/31718044
http://dx.doi.org/10.3390/cells8111419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912224/
https://www.ncbi.nlm.nih.gov/pubmed/31718044
http://dx.doi.org/10.3390/cells8111419

Ejemplares similares